Cloning, expression, and purification of C-terminal quarter of the heavy chain of botulinum neurotoxin type A

Protein Expression and Purification

Volumn 45, Issue 2, 2006, Pages 288-295

  Sharma, Sapna ^a   Zhou, Yu ^a   Singh, Bal Ram ^a  

^a UNIVERSITY OF MASSACHUSETTS DARTMOUTH   (United States)

Author keywords

Botulinum; Dot blot; Expression; Gangliosides; Neurotoxin; Purification; Receptor

Indexed keywords

BOTULINUM TOXIN A; GANGLIOSIDE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; SYNAPTOTAGMIN;

ARTICLE; CHEMISTRY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; PROTEIN CONFORMATION;

BOTULINUM TOXIN TYPE A; CLONING, MOLECULAR; GANGLIOSIDES; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SYNAPTOTAGMINS;

ESCHERICHIA COLI; LOTUS;

EID: 31044444759     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2005.07.020     Document Type: Article

References (26)

1. L. Li, and B.R. Singh Structure-function relationship of clostridial neurotoxins J. Toxicol. 18 1999 95 112
2. B.R. Singh Critical aspects of bacterial protein toxins Adv. Exp. Med. Biol. 391 1996 63 84
3. B.R. Singh Intimate details of the most poisonous poison Nature. Struct. Biol. 7 2000 617 619
4. C. Montecucco, and G. Schiavo Mechanism of action of tetanus and botulinum neurotoxins Microbiology 13 1994 1 8
5. C. Montecucco How do tetanus and botulinum toxins bind to neuronal membrane Trends Biochem. Sci. 11 1986 314 317
6. CC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction Mol. Microbiol. 51 2004 631 643
7. F. Fu, R. Lomneth, S. Cai, and B.R. Singh Role of zinc in the structure and toxic activity of botulinum neurotoxin Biochemistry 37 1998 5267 5278
8. G. Schiavo, O. Rossetto, and C. Montecucco Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release Semin. Cell Biol. 5 1994 221 229
9. CC-domain of tetanus neurotoxin are required for toxicity J. Mol. Biol. 326 2003 835 847
10. M. Kitamura, K. Takamiya, S. Aizawa, K. Furukawa, and K. Furukawa Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice Biochim. Biophys. Acta 1441 1999 1 3
11. T1b as a complementary receptor component for clostridium botulinum neurotoxins Microb. Pathog. 25 1998 91 99
12. L. Li, and B.R. Singh Isolation of synaptotagmin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a new microtiter plate assay J. Nat. Toxins 7 1998 215 226
13. K. Ginalski, C. Venclovas, B. Lesyng, and K. Fidelis Structure-based sequence alignment for the beta-trefoil subdomain of the clostridial neurotoxin family provides residue level information about the putative ganglioside binding site FEBS Lett. 482 2000 119 124
14. D.B. Lacy, W. Tepp, A.C. Cohen, B.R. DasGupta, and R.C. Stevens Crystal structure of botulinum neurotoxin type A and implications for toxicity Nat. Struct. Biol. 5 1998 898 902
15. T. Binz, H. Kurazono, M. Wille, J. Frevert, K. Wernars, and H. Neimann The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins J. Biol. Chem. 265 1990 9153 9158
16. P. Emsley, C. Fotinou, I. Black, N.F. Fairweather, I.G. Charles, C. Watts, E. Hewitt, and N.W. Isaacs The structures of the H(C) fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding J. Biol. Chem. 275 2000 8889 8894
17. J.M. Sutton, L. Spaven, N.J. Silman, B. Hallis, O. Chow-Worn, and C.C. Shone The receptor binding domains of clostridial neurotoxins M.F. Brin J. Jankovic M. Hallett Scientific and Therapeutic Aspects of Botulinum Toxin 2002 Lippincott Williams and Wilkins Philadelphia 41 48
18. C. Montecucco, O. Rossetto, and G. Schiavo Presynaptic receptor arrays for clostridial neurotoxins Trends Microbiol. 12 2004 442 446
19. L.A. Smith, and M.P. Byrne Vaccines for preventing botulism M.F. Brin J. Jankovic M. Hallett Scientific and Therapeutic Aspects of Botulinum Toxin 2002 Lippincott Williams and Wilkins Philadelphia 427 437
20. L.L. Simpson Identification of the characteristics that underlie botulinum toxin potency: implications for designing novel drugs Biochimie 82 2000 943 953
21. L.A. Smith Development of recombinant vaccines for botulinum neurotoxin Toxicon 36 1998 539 1548
22. M. Tavallaie, A. Chenal, D. Gillet, Y. Pereira, M. Manich, M. Gibert, S. Raffestin, M.R. Popoff, and J.C. Marvaud Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies FEBS Lett. 572 2004 299 306
23. L. Li, and B.R. Singh In vitro translation of type A clostridium botulinum neurotoxin heavy chain and analysis of its binding to rat synaptosomes J. Protein Chem. 18 1999 89 95
24. J.R. Whitaker, and P.E. Granum An absolute method for protein determination based on difference in absorbance at 235 and 280 nm Anal. Biochem. 109 1980 156 159
25. S. Cai, H.K. Sarkar, and B.R. Singh Enhancement of the endopeptidase activity of botulinum neurotoxin by its associated proteins and dithiothreitol Biochemistry 38 1999 6903 6910
26. Y. Zhou, and B.R. Singh Cloning, high level expression, single step purification and binding activity of His6-tagged recombinant type B Botulinum neurotoxin heavy chain transmembrane and binding domain Protein Expr. Purif. 34 2004 8 16